ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 7 filers reported holding ERYTECH PHARMA in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $523,000 | -38.7% | 117,837 | -1.0% | 0.08% | -30.8% |
| Q2 2019 | $853,000 | -6.5% | 119,037 | -0.8% | 0.12% | +41.0% |
| Q1 2019 | $912,000 | +14.6% | 120,000 | 0.0% | 0.08% | -7.8% |
| Q4 2018 | $796,000 | -23.9% | 120,000 | 0.0% | 0.09% | -25.0% |
| Q3 2018 | $1,046,000 | -58.5% | 120,000 | 0.0% | 0.12% | -68.7% |
| Q1 2018 | $2,520,000 | -4.6% | 120,000 | 0.0% | 0.38% | +23.5% |
| Q4 2017 | $2,642,000 | – | 120,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,314,656 | $690,000 | 0.03% |
| Vanguard Personalized Indexing Management, LLC | 59,839 | $33,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,005 | $6,000 | 0.00% |
| Asset Dedication, LLC | 4,000 | $2,000 | 0.00% |
| Ikarian Capital, LLC | 3,019 | $2,000 | 0.00% |
| UBS Group AG | 4,320 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 10,590 | $6,000 | 0.00% |
| Mariner, LLC | 59,472 | $33,000 | 0.00% |
| Citadel Advisors | 18,181 | $10,000 | 0.00% |